- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02057952
HealthyMe Online Weight Management Education/HealthyMe at Home (HOME)
RCT of Video-Conference & In-Person Weight Loss Services for Adult CHC Patients
The main objective for this project is to identify effective methods of treating obesity in at-risk populations. The investigators will be comparing weight loss from usual care, in person, and video conference weight loss programs. The investigators will follow 210 participants for 12 months to see if they lose and maintain 2kg of weight. The investigators will also compare the costs of video conference versus in person administered programs.
Potentially eligible participants will be identified based on data in the Regenstrief Medical Records System or by referral from the Wishard HealthyMe weight loss program staff or a Wishard Community Health Center (CHC) primary care provider. The PBRN staff will carry-out initial recruitment. Following consent, a baseline assessment will be performed and each participant will be randomized into one of three groups: usual care control, in person weight loss or online video conference weight loss. At 6 and 12 months a follow up assessment will be performed and compared to measures from the investigators baseline assessment. Total costs for each program will be compared as well.
The weight loss interventions involve group meetings two times per week where education, exercise, and social support are provided. Participants will also receive a detailed education booklet. Those randomized to the in-person group will meet in the CHC and those in the video-conference group will meet online in a multi-party video-conference. All participants will receive usual CHC care.
Study Overview
Detailed Description
Recruitment will occur in person or by phone by the Practice Based Research Network (PBRN). Prior to recruitment, patients will have been identified as potentially eligible by having a BMI of ≥30<50, age 40-64 years, Community Health Center visit within 12 months and no type 2 diabetes, psychosis or bipolar disorder, current cancer treatment or medication prescriptions for drugs that may unduly influence weight. All of this would be determined from the Regenstrief Medical Records System, by referral from HealthyMe staff, or a CHC primary care provider. Potentially eligible persons must then be approved for the study and moderate-intensity exercise by their primary care provider before the recruitment call and screener from the PBRN. The screener assesses other eligibility criteria such as recent weight loss program enrollment, current physical activity level, residence plans, phone availability, etc. Those who are eligible and initially interested will be referred to the study staff.
Staff will call, describe the study and arrange for an in-home appointment with the potential participant. At the participant's home, the staff will again describe the study and consent the participant. The first assessment will take place at this time. The baseline assessment pertains of demographic questions, living situation questions, smoking status, weight history, Patient Health Questionnaire (PHQ), New Vital Sign (NVS) Nutrition Literacy and Numeracy Survey, the Subjective Numeracy Scale, Short Form 36, Social Support and Exercise, Social Support and Eating Habits, Exercise enjoyment scales, Wellness Evaluation of Lifestyle (WEL), low fat diet efficacy scale, exercise self efficacy scale, and an online dietary recall (ASA 24) provided by the National Cancer Institute as well as blood pressure, weight, height and waist circumference. They will also be asked to wear an armband accelerometer for two weeks to let the staff know how much energy they are expending.
The participants will be randomized to three different arms: usual care, in center education and exercise, or education and exercise via video conference. The attached handouts, placemats, as well as portion control dinnerware will be given to the active arms of the study. The sessions for both groups will occur twice a week for approximately 75 minutes. Those randomized to the video conference arm will have a computer with Internet access installed in their home. All Internet related expenses will be covered by the study during the duration of the classes and the computer will be removed at the end of the study.
Sessions for the two active arms will occur twice per month in months 6-9 and once a month for months 10-12. They will include an exercise and educational portion to last about 75 minutes.
We will be measuring change in weight, body measurements and improvements in the NVS at six months and have a final assessment at 12 months. They will again be asked to wear the accelerometer for two weeks and to answer the questions in the attached survey. Their weight and blood pressure will again be recorded.
During the course of the study, participants may need to be called to set up appointments, remind them of sessions or assist them with their equipment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46205
- Indiana University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- One or more community health visits in the past 12 months
- Body mass index (BMI) of ≥30<50
- English Speaking
- Access to a telephone
- A residence
- Willingness to be randomized
- Willingness to have a computer installed in the home
- Weight loss referral from CHC provider
Exclusion Criteria:
- Current diagnosis of type 2 diabetes
- Current treatment for cancer
- Current diagnosis of psychosis or bipolar disorder
- Illness that might be associated with weight change, such as asthma, (because of treatment with corticosteroids), psychosis
- Use of medications that might cause weight gain or loss such as hypoglycemic oral medicines or insulin, corticosteroids, some anti-depressants, weight loss medications
- Unwilling or unable to provide informed consent
- Receiving disability insurance
- Pregnant or nursing in the past six months, or plans to become so within 12 months
- Residence outside of Marion County, Indiana
- Residence relocation plans within 12 months
- Enrolled in weight loss program within past 6 months
- Meeting physical activity guidelines
- Planned or prior bariatric surgery
- Substance abuse
- History of treatment for eating disorder
- Unstable weight gain or loss of ≥5% in the last 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care Control
No intervention.
|
|
Active Comparator: In Person Weight Management
Education and exercise in a community health center environment.
|
The active groups will meet twice a week for 75 minutes over six months.
They will be followed for an addition six months to monitor maintenance.
|
Experimental: Video Conference Weight Management
Education and exercise delivered through video conference.
|
The active groups will meet twice a week for 75 minutes over six months.
They will be followed for an addition six months to monitor maintenance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Weight
Time Frame: Baseline to 12 Months
|
Change in weight from baseline to 12 months reported in pounds.
|
Baseline to 12 Months
|
Attendance Reported in Minutes
Time Frame: 12 Months
|
Minutes of participation in study sessions.
|
12 Months
|
Change in Body Weight From Baseline to 6 Months.
Time Frame: 12 months
|
Change in body weight from baseline to 6 months.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Short Form 36 Survey Score
Time Frame: Baseline to 12 Months
|
The Short Form 36 survey or Short-Form 36 is a patient report survey.
Scores range from 0 (worst) to 100 (best) and represent overall health-related quality of life.
|
Baseline to 12 Months
|
Change in Systolic Blood Pressure
Time Frame: 12 Months
|
Systolic blood pressure.
Measured using blood pressure cuff and sphygmomanometer.
Units in Milometers of Mercury (mmHg).
Scale range is based on participants' actual blood pressure (change baseline to 12 months).
Negative value indicates decrease in blood pressure.
|
12 Months
|
Cost-effectiveness
Time Frame: 12 months
|
The cost effectiveness ratios were calculated by dividing the difference in total cost per arm by the difference in percent of subjects with 2+ kg weight loss
|
12 months
|
Change in SF 36 From Baseline to 6 Months
Time Frame: 6 Months
|
The Short Form 36 survey or Short-Form 36 is a patient report survey.
Scores range from 0 (worst) to 100 (best) and represent overall health-related quality of life.
|
6 Months
|
Change in Systolic Blood Pressure
Time Frame: 6 Months
|
Change in pressure from baseline to 6 months
|
6 Months
|
Change in Diastolic Blood Pressure at 6 Months
Time Frame: 6 Months
|
Change in pressure from baseline to 6 months
|
6 Months
|
Change in Diastolic Blood Pressure Baseline to 12 Months
Time Frame: 12 Months
|
Diastolic blood pressure change from baseline to 12 months.
Measured using blood pressure cuff and sphygmomanometer.
Units in Milometers of Mercury (mmHg).
Scale range is based on participants' actual blood pressure (change baseline to 12 months; negative value indicates decrease in blood pressure).
|
12 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel O. Clark, Ph.D, Indiana University School of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1201007860
- NIDDK (DK092377)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on Education and exercise
-
University of MelbourneCompleted
-
Ruth ChimentiDepartment of Health and Human ServicesCompleted
-
Western University, CanadaUnknown
-
Göteborg UniversityThe Swedish Research CouncilCompleted
-
Slagelse HospitalRegion ZealandCompleted
-
University of Illinois at Urbana-ChampaignCompletedMultiple Sclerosis | Adult DiseaseUnited States
-
George Washington UniversityTerminatedBreast Cancer | ArthralgiaUnited States
-
Aveiro UniversityFoundation for Science and Technology, PortugalCompletedChronic Neck PainPortugal
-
Oslo Metropolitan UniversityCompleted
-
University College DublinCompletedSpondylitis, AnkylosingIreland